喘中的环境可持续性:减少碳足迹和药物浪费
Ming Ren Toh1,2, Shu Wei Ang3, Gerald Xuan Zhong Ng4
1Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore, Singapore. mingren.toh@mohh.com.sg.
概括
喘吸入器对温室气体排放作出了重大贡献. 减少药物浪费和供应过剩,特别是ICS-LABA MDIs,可以降低喘护理的碳足迹.
科学领域:
- 环境健康 环境健康
- 制药科学 制药科学
- 公共卫生 公共卫生
背景情况:
- 喘吸入器是温室气体排放的重要来源.
- 由于吸入器使用而造成的药物浪费和供应过剩对环境的影响尚不清楚.
- 这项研究调查了与喘吸入器分发模式相关的可避免的碳足迹.
研究的目的:
- 分析喘吸入器分发模式和相关的碳足迹.
- 量化喘患者的药物浪费和供应过剩.
- 确定导致药物供应过剩的因素.
主要方法:
- 对2015-2019年喘吸入器发行记录的回顾性审查.
- 分析药物浪费 (每次补充间隔过多的吸入器) 和供应过剩 (MPR>1.2).
- 使用一个链接的电子健康记录存储库来存储患者和发行数据.
主要成果:
- 发放的吸入器单位超过205,000个,产生约150万公斤CO2e.
- 吸入类皮质类固醇长效β-agonist计量剂量吸入器 (ICS-LABA MDIs) 是最大的碳足迹贡献者.
- 发现了大量的药物浪费,其中贝克洛梅他MDIs是主要来源;初级保健患者显示出更高的供应过剩率.
结论:
- ICS-LABA MDIs是喘吸入器碳足迹的主要驱动因素.
- 过度使用吸入器有助于环境浪费.
- 解决供应过剩问题,特别是在初级保健中,对于减少碳足迹至关重要.
相关概念视频
Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Asthma-IV: Nursing Management
3.7K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.7K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
COPD: Management Using Bronchodilators and Corticosteroids
734
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
734
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Inhaled Medications
749
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
749


